Related Experiment Video

Updated: Apr 4, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.6K

MiR-622 inhibited colorectal cancer occurrence and metastasis by suppressing K-Ras

Yantian Fang1,2, Bo Sun2, Zhenyang Li2

  • 1Department of Gastric Cancer and Soft Tissue Sarcoma, Fudan University Shanghai Cancer Center, China.

Molecular Carcinogenesis
|September 3, 2015
PubMed

Insights

MicroRNA 622 (miR-622) is downregulated in colorectal cancer (CRC), inhibiting tumor growth and migration. Restoring miR-622 may offer new therapeutic strategies for CRC by targeting the K-Ras pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a major global health concern, driven by complex genetic alterations.
  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer development.
  • Understanding specific miRNA roles, like miR-622, is crucial for CRC research.

Purpose of the Study:

  • To investigate the role and mechanism of miR-622 in colorectal cancer.
  • To identify direct targets of miR-622 within CRC cells.
  • To explore the therapeutic potential of the miR-622 pathway in CRC.

Main Methods:

  • Quantitative analysis of miR-622 expression in CRC tissues and cell lines.
  • In vitro assays to assess the effects of miR-622 on tumor cell proliferation and migration.
  • Dual-luciferase reporter assays to confirm direct gene targets.
  • Validation in a colon xenograft tumor model.
  • Kirsten rat sarcoma (K-Ras) gene expression analysis.

Main Results:

  • miR-622 was significantly downregulated in colorectal tumor tissues and cell lines compared to normal controls.
  • Lower miR-622 levels correlated with tumor metastasis.
  • Overexpression of miR-622 suppressed CRC cell proliferation and migration in vitro.
  • Kirsten rat sarcoma (K-Ras) was identified as a direct target of miR-622.
  • K-Ras overexpression rescued the inhibitory effects of miR-622, confirming its role in the pathway.
  • Findings were validated in vivo using a colon xenograft model.

Conclusions:

  • miR-622 acts as a tumor suppressor in colorectal cancer.
  • The miR-622-K-Ras signaling pathway represents a novel target for CRC screening and therapy.
  • Modulating miR-622 levels holds promise for future CRC treatment strategies.
Keywords:
K-Rascolorectal cancermetastasismiR-622

More Related Videos

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

6.1K
Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer06:19

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

10.9K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K